Related Experiment Videos
[Biosynthesis and significance of acute phase proteins]
Abstract:
Acute phase proteins (APP) increase by the chemical receptors of macrophage via stimulations of either Fc or complement or other chemical receptors. No differences of APP pattern were observed by the different stimulants, because the effects of stimulation are changed by many processing steps in the macrophage as well as in the liver cell thereafter. Whether the APP increase results in good prognosis for original sickness or not are examined by multiple regression analysis in 38 cases of maxillary and 51 cases of laryngeal cancer with the observation for over five years. Alpha 1X contributes positively with length of their life, whereas alpha 1AG and ceruloplasmin contribute negatively. We could say that not all components of APP increase are advantageous for the diseases.
Insights
Acute phase proteins (APP) can be influenced by various stimuli. While some APP, like Alpha 1X, may improve cancer patient survival, others, such as alpha 1AG and ceruloplasmin, can negatively impact prognosis.
Area of Science:
- Biochemistry
- Immunology
- Oncology
Context:
- Acute phase proteins (APP) are key inflammatory markers.
- Macrophage stimulation via Fc, complement, or other receptors triggers APP production.
- The complex cellular processing of these stimuli obscures direct correlations with specific APP patterns.
Purpose:
- To investigate the prognostic significance of elevated acute phase proteins in cancer patients.
- To determine if increased APP levels correlate with patient survival outcomes.
- To analyze the differential impact of specific APP components on prognosis.
Summary:
- APP levels increase following macrophage stimulation, irrespective of the specific stimulant, due to complex intracellular processing.
- Multiple regression analysis of 38 maxillary and 51 laryngeal cancer cases over five years revealed prognostic differences among APP.
- Alpha 1X was associated with increased survival, while alpha 1AG and ceruloplasmin showed negative correlations with longevity.
Impact:
- Findings suggest that not all increases in APP are beneficial for cancer patients.
- Highlights the need for nuanced interpretation of APP levels in clinical oncology.
- Provides a basis for further research into specific APP roles in cancer progression and patient outcomes.